Related Experiment Videos
Genomic cross-talk between the estrogen receptor and growth factor regulatory pathways in estrogen target tissues
D Chalbos1, A Philips, H Rochefort
1Institut National de la Santé et de la Recherche Médicale, Unité Hormones et Cancer (U 148), Montpellier, France.
Abstract:
Cell proliferation and differentiation are modulated by both estrogens and growth factors. Even though these two kinds of effectors interact with receptors localized in different compartments of the cell, their nuclear end points are often on the same genes. We review here the first evidence for transcriptional interference between these two regulatory pathways which might be essential in understanding the control of cell proliferation and invasion in human estrogen-responsive cancers.
Insights
Estrogens and growth factors, crucial for cell growth, can interfere at the gene level. This interaction is key to understanding estrogen-responsive cancers and their invasion.
Area of Science:
- Molecular biology
- Cancer research
- Cell signaling
Background:
- Cell proliferation and differentiation are regulated by estrogens and growth factors.
- These signaling pathways interact with cellular receptors in different compartments.
- Both pathways often converge on the same target genes within the nucleus.
Purpose of the Study:
- To review the initial evidence of transcriptional interference between estrogen and growth factor signaling.
- To explore the implications of this interference in human estrogen-responsive cancers.
Main Methods:
- Literature review of existing studies on estrogen and growth factor signaling pathways.
- Analysis of molecular mechanisms underlying transcriptional regulation.
- Examination of gene expression data in the context of cancer biology.
Main Results:
- The study presents the first evidence of transcriptional interference between estrogen and growth factor signaling pathways.
- This interference occurs at the level of gene transcription, despite receptors being in different cellular compartments.
- The convergence of these pathways on common genes is a significant finding.
Conclusions:
- Transcriptional interference between estrogens and growth factors is a critical mechanism in cellular regulation.
- Understanding this crosstalk is essential for comprehending the control of cell proliferation and invasion in estrogen-responsive cancers.
- This finding opens new avenues for therapeutic strategies targeting cancer progression.